The global coronary artery bypass graft market is projected to reach USD 18,700.6 million by 2025 and continue its upward trajectory with a CAGR of 2.9%, reaching approximately USD 24,887.3 million by ...

Aims: Coronary artery bypass grafts (CABGs) are increasingly performed in elderly patients. Risk factors and outcomes are poorly described for those undergoing noncardiac surgery within 1 year ...

Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the ...

Objectives: To quantify the incidence of major adverse events (AEs) occurring in hospital or within 30 days after surgery in patients undergoing coronary artery bypass graft (CABG) surgery and to ...

MIDCAB, minimally invasive direct coronary artery bypass grafting for single-vessel LIMA-LAD. MICS-CABG, minimally invasive cardiac surgery for multivessel bypass grafting. CABG, coronary artery ...

Table 2. Variables and outcomes for patients who underwent a noncardiac surgical procedure after coronary artery bypass grafting (n = 211). † Values expressed as number (%) of patients ...

Chief Dr. Shalimar S. Rakiin and PhilHealth-BARMM Regional Vice President Datu Masiding M. Alonto Jr. sign a memorandum of ...

Despite improvements, Black patients vs White patients in the United States, as of 2019, continue to be less likely to receive coronary artery bypass grafting (CABG) at the lowest mortality hospitals ...

Objective Coronary artery bypass grafting (CABG) is an established revascularisation strategy for multivessel and left main coronary artery disease. Although aspirin is routinely recommended for ...

In a new study published in Cell Reports Medicine, they built upon that work to create a universal, small diameter, vascular ...

Preoperative anemia does not affect the long-term survival advantage associated with coronary artery bypass grafting (CABG) in patients with ischemic cardiomyopathy (ICM). What is known and what ...